Skip to main content

Table 3 Clinical and Cognitive Outcomes of the Subset of Participants with Follow-up (n = 54)a

From: Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong – a single center study

  Baseline Follow-up p-value
CD4+ T-lymphocyte (cells/μL) 248 (46–355) 468 (261–673) < 0.001
On cART with CPE > 7, n (%) 7 (13)
HIV-1 RNA suppressionb, n (%) 46 (85)
IHDS score 10 (10–11) 11 (10–12) < 0.001
IHDS ≤10, n (%) 31 (57) 17 (32) < 0.001
MoCA score 27 (26–29) 27 (26–28) 0.818
MoCA ≤25, n (%) 13 (24) 12 (22) 1.000
MoCA ≤21, n (%) 4 (7) 4 (7) 1.000
  1. Median (IQR) is presented unless specified otherwise
  2. aOnly included participants who were on cART
  3. bBlood HIV-1 RNA level < 20 copies/mL
  4. Abbreviations: IHDS International HIV Dementia Scale, MoCA Montreal Cognitive Assessment, CPE CNS penetration-effectiveness